Richard Press, MD is among the co-authors in a study published in the J Molecular Diagnostics

2013

Sep
01

Richard Press, MD is among the co-authors in a study published in the J Molecular Diagnostics

Knight Diagnostic Laboratories' Richard Press, MD is among the co-authors in a study just published in the J Molecular Diagnostics "BCR-ABL1 RT-qPCR for Monitoring the Molecular Response to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia ." Read More Here

Previous Article Next Article

Back To List

More in

News and Events

Innovations in Testing

View All Tests

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More

About UsNews & Events

Richard Press, MD is among the co-authors in a study published in the J Molecular Diagnostics

GeneTrails®Comprehensive Solid Tumor Panel

GeneTrails® Hematologic - Malignancies 220 Gene Panel

GeneTrails® Solid Tumor Fusion Gene panel

Genome-Wide DNA Methylation Array

Oncology Microarray - Targeted Gene and Region Panel

Inherited Cancer Panel

Quanitative Intracelluar Signaling Panel - Research Only

Chromosomal Microarray - Prenatal Diagnosis